As drug development costs increase, the process of drug development is becoming more and more complex. Those involved with the process of developing new therapeutics (drugs, devices, combination products and diagnostics) must understand the process and be able to navigate it with great skill. These skills are difficult to acquire.

This program will provide a unique opportunity to obtain a hands-on insight into the drug development process from drug discovery (designation of a lead) to registration. The major aspects of development will be considered in detail.

Who should attend?

• CEOs, CFOs, COOs of small and virtual companies
• Large pharma professionals
• Executives involved with the drug development process
• Regulatory affairs professionals
• Clinical research professionals
• Senior Scientists,toxicologists, etc.